Search

Search Constraints

You searched for: Author/Creator Sigala, Sandra

Search Results

1. Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. Issue 6 (December 2019)

2. Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?. (13th August 2022)

5. Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420–425]. (January 2015)

7. In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. (1st December 2019)

8. Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials. (May 2016)

9. Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials. (May 2016)